Symbol="LTRN"
AssetType="Common Stock"
Name="Lantern Pharma Inc"
Description="Lantern Pharma Inc., a clinical-stage biotechnology company, focuses on developing precision cancer therapies using artificial intelligence, genomics, and machine learning. The company is headquartered in Dallas, Texas."
CIK="1763950"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="55479000"
EBITDA="-14641114"
PERatio="None"
PEGRatio="None"
BookValue="4.843"
DividendPerShare="0"
DividendYield="0"
EPS="-1.34"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.148"
ReturnOnEquityTTM="-0.238"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.34"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="17.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.993"
EVToRevenue="-"
EVToEBITDA="-0.0633"
Beta="0.67"
num_52WeekHigh="6.59"
num_52WeekLow="4.05"
num_50DayMovingAverage="5.24"
num_200DayMovingAverage="5.13"
SharesOutstanding="10857000"
DividendDate="None"
ExDividendDate="None"
symbol="LTRN"
open="5.18"
high="5.34"
low="5.06"
price="5.21"
volume="25478.00"
latest_trading_day="2023-07-07"
previous_close="5.11"
change="0.10"
change_percent="1.9569%"
aroon_positive_momentum_days="43"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="43"
Volume_recent_avg="33241"
Change_recent_avg="-0.03"
Delta_recent_avg="0.32"
Variance_recent_avg="0.16"
Change_ratio_recent_avg="-0.72"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="43"
Aroon_momentum_negative="57"
image_negative_thumbnail_id_1="1162"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0196.jpeg"
image_negative_thumbnail_id_2="141"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0035.jpeg"
image_neutral_thumbnail_id_1="589"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_neutral_thumbnail_id_2="585"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_positive_thumbnail_id_1="949"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0111.jpeg"
image_positive_thumbnail_id_2="984"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
